How best to administer surfactant to VLBW infants?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 4, 2011, Pages

  Kribs, Angela ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ARTIFICIAL VENTILATION; ASSISTED VENTILATION; EDITORIAL; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; EXTUBATION; GENETIC RISK; GESTATIONAL AGE; HUMAN; INFANT; LARYNGOSCOPY; LUNG DYSPLASIA; LUNG EMPHYSEMA; MORBIDITY; MORTALITY; NEBULIZATION; NEBULIZER; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY DISTRESS; RISK FACTOR; SURVIVOR; VERY LOW BIRTH WEIGHT;

COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 79959814696     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2010.209098     Document Type: Editorial

References (31)

1. Seger N, Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009;2:CD007836.
2. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001;2:CD000510.
3. Stevens TP, Harrington EW, Blennow M, et al. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007;4:CD003063.
4. Kamper J. Early nasal continuous positive airway pressure and minimal handling in the treatment of very-low-birth-weight infants. Biol Neonate 1999;76(Suppl 1):22-8. (Pubitemid 29281293)
5. Verder H. Nasal CPAP has become an indispensable part of the primary treatment of newborns with respiratory distress syndrome. Acta Paediatr 2007;96:482-4. (Pubitemid 46466128)
6. Vanpée M, Walfridsson-Schultz U, Katz-Salamon M, et al. Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm. Acta Paediatr 2007;96:10-16.
7. Jónsson B, Katz-Salamon M, Faxelius G, et al. Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Paediatr Suppl 1997;419:4-10. (Pubitemid 27244704)
8. Hansen BM, Hoff B, Uldall P, et al. Perinatal risk factors of adverse outcome in very preterm children: a role of initial treatment of respiratory insufficiency? Acta Paediatr 2004;93:185-9. (Pubitemid 38230712)
9. Lundstrøm KE. Early nasal continuous positive airway pressure for preterm neonates: the need for randomized trials. Acta Paediatr 2003;92:1124-6. (Pubitemid 37297088)
10. Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700-8. (Pubitemid 351240749)
11. Finer NN, Carlo WA, Walsh MC, et al.; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362:1970-9.
12. Verder H, Agertoft L, Albertsen P, et al. Surfactant treatment of newborn infants with respiratory distress syndrome primarily treated with nasal continuous positive air pressure. A pilot study. Ugeskr Laeg 1992;154:2136-9.
13. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994;331:1051-5. (Pubitemid 24317697)
14. Verder H, Albertsen P, Ebbesen F, et al. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24.
15. Sandri F, Plavka R, Ancora G, et al. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010;125:e1402-9.
16. Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Curr Opin Pediatr 2007;19:155-62. (Pubitemid 46668067)
17. Jorch G, Hartl H, Roth B, et al. Surfactant aerosol treatment of respiratory distress syndrome in spontaneously breathing premature infants. Pediatr Pulmonol 1997;24:222-4. (Pubitemid 27431233)
18. Arroe M, Pedersen-Bjergaard L, Albertsen P, et al. Inhalation of aerosolized surfactant (Exosurf®) to neonates treated with nasal continuous positive airway pressure. Prenat Neonat Med 1998;3:346-52. (Pubitemid 128692706)
19. Berggren E, Liljedahl M, Winbladh B, et al. Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome. Acta Paediatr 2000;89:460-4. (Pubitemid 30636828)
20. Finer N, Merritt T, Bernstein G, et al. A multicenter pilot study of Aerosurf delivered via nasal continuous positive airway pressure (nCPAP) to prevent respiratory distress syndrome in preterm neonates. Pediatr Res 2006;59:PAS2006:4840.138.
21. Finer NN, Merritt TA, Bernstein G, et al. An open label, pilot study of Aerosurf(®) combined with nCPAP to prevent RDS in preterm neonates. J Aerosol Med Pulm Drug Deliv 2010;23:303-9.
22. Arzhavitina A, Steckel H. Surface active drugs significantly alter the drug output rate from medical nebulizers. Int J Pharm 2010;384:128-36.
23. Kattwinkel J, Robinson M, Bloom BT, et al. Technique for intrapartum administration of surfactant without requirement for an endotracheal tube. J Perinatol 2004;24:360-5. (Pubitemid 38931090)
24. Brimacombe J, Gandini D, Keller C. The laryngeal mask airway for administration of surfactant in two neonates with respiratory distress syndrome. Paediatr Anaesth 2004;14:188-90. (Pubitemid 38297230)
25. Trevisanuto D, Grazzina N, Ferrarese P, et al. Laryngeal mask airway used as a delivery conduit for the administration of surfactant to preterm infants with respiratory distress syndrome. Biol Neonate 2005;87:217-20. (Pubitemid 41094904)
26. Micaglio M, Zanardo V, Ori C, et al. ProSeal LMA for surfactant administration. Paediatr Anaesth 2008;18:91-2.
27. Kribs A, Pillekamp F, Hünseler C, et al. Early administration of surfactant in spontaneous breathing with nCPAP: feasibility and outcome in extremely premature infants (postmenstrual age
28. Kribs A, Vierzig A, Hünseler C, et al. Early surfactant in spontaneously breathing with nCPAP in ELBW infants - a single centre four year experience. Acta Paediatr 2008;97:293-8. (Pubitemid 351514153)
29. Kribs A, Härtel C, Kattner E, et al. Surfactant without intubation in preterm infants with respiratory distress: first multi-center data. Klin Padiatr 2010;222:13-17.
30. Dargaville PA, Aiyappan A, Cornelius A, et al. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2011;4:F243-8.
31. Shah S. Exogenous surfactant: intubated present, nebulized future? World J Pediatr 2011;7:11-15.